Molecular approaches to colorectal cancer: A review

Current Diagnostic Pathology

Volumn 5, Issue 1, 1998, Pages 34-43

  Sutherland, F ^a   Haine, L ^a   Quirke, P ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0003151407     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-6053(98)80032-X     Document Type: Article

References (88)

1. Knudson A G. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sei USA 197I; 68: 820-823.
2. Cavenee W K, Dryja T P, Phillips R A et al. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 1983; 305:779-784.
3. Hockenbery D, Nunez G, Millman C, Schreiber R D, Korsemeyer S J. Bcl-2 is an inner mitochondria! membrane protein that blocks programmed cell death. Nature 1990; 348: 334-336.
4. Golstein P. Controlling cell death. Science 1997; 275: 1081-1082.
5. Tahara H, Kuniyasu H, Yokozaki H et al. Telomerase activity in preneoplastic and neoplastic gastric and neoplastic gastric and colorectal lesions. Clin Cancer Res 1995; 1: 1245-1251.
6. Arber N, Hibshoosh H, Moss S et al. Increased expression of cyclin Dl is an early event in multistage colorectal carcinogenesis. Gastroenterology 1996; 110: 669-674.
7. Brown J P, Wei W, Sedivy J M. Bypass of senescence after disruption of p21 CIP1AVAF1 gene in normal diploid human fibroblasts. Science 1997; 277: 831-834.
8. Steeg P S, Bevilacqua G, Kopper L et al. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 1988; 80: 200-204.
9. Arch R, Wirth K, Hofmann M et al. Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 1992; 257: 682-687.
10. Jarvinen H J. Epidemiology of familial adenomatous polyposis in Finland: impact of family screening on the colorectal cancer rate and survival. Gut 1992; 33: 353-360.
11. Bodmer W F, Bailey C J, Bodmer J et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987; 328: 1411-1413.
12. Groden J, Thliveris A, Samowitz W et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66:589-600.
13. Spirio L, Otterud B, Stauffer D et al. Linkage of a variant or attenuated form of adenomatous polyposis coli to the adenomatous polyposis coli (APC) locus. Am J Hum Genet 1992:51:92-100.
14. Laken S J, Petersen G M, Gruber S B et al. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 1997; 17: 79-83.
15. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P. Binding of GSK3 to the APC-Catenin complex and regulation of complex assembly. Science 1996; 272: 1023-1026.
16. Peifer M.B-Catenin as oncogene: the smoking gun. Science 1997; 275: 1752-1753.
17. Korinek V, Barker N, Morin P J et al. Constitutive transcriptional activation by a -catenin-tcf complex in APC7 colon carcinoma. Science 1997; 275: 1784-1787.
18. Morin P J, Sparks A B, Korinek V et al. Activation of -catenintcf signalling in colon cancer by mutations in -catenin or APC. Science 1997; 275: 1787-1790.
19. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P. Stabilization of -catenin by genetic defects in melanoma cell lines. Science 1997; 275: 1790-1793.
20. Vider B Z, Zimber A, Chastre E et al. Evidence for the involvement of the Wnt 2 gene in human colorectal cancer. Oncogene 1996; 12: 153-158.
21. Smith K J, Levy D B, Maupin P, Pollard T D, Vogelstein B, Kanzler K W. Wild-type but not mutant APC associates with the microtubule cytoskeleton. Cancer Res 1994; 54: 3672-3675.
22. Munemitsu S, Souza B, Muller O, Albert I, Rubinfeld B, Polakis P. The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res 1994; 54:3676-3681.
23. Lynch H T, Watson P, Smyrk T C et al. Colon cancer genetics. Cancer 1992; 70(5 Suppl): 1300-1312.
24. Vasen H F A. What is Hereditary Nonpolyposis Colorectal Cancer (HNPCC)? Anticancer Res 1994; 14: 1613-1616.
25. Peltomaki P, Aaltonen L A, Sistonen P et al. Genetic mapping of a locus predisposing to Human Colorectal Cancer. Science 1993; 260: 810-812.
26. Aaltonen L A, Peltomaki P, Leach F S et al. Clues to the pathogenesis of Familial Colorectal Cancer. Science 1993; 260:812-816.
27. Thibodeau S N, Bren G, Schaid D. Microsatellite instability in the proximal colon. Science 1993; 260: 816-819.
28. Chung D C, Rustgi A K. DMA mismatch repair and cancer. Gastroenterology 1995; 109: 1685-1699.
29. Fishel R, Lescoe M K, Rao M R S et al. The human mutator gene homolog MSH2 and its association with Hereditary Nonpolyposis Colon Cancer. Cell 1993; 75: 1027-1038.
30. Leach F S, Nicolaides N C, Papadopoulos N et al. Mutations of a MutS homolog in Hereditary Non-Polyposis Colorectal Cancer. Cell 1993; 75: 1215-1225.
31. Bronner C E, Baker S M, Morrison P T et al. Mutation in thé DNA mismatch repair gene homologue hMLHl is associated with Hereditary Non-Polyposis Colon Cancer. Nature 1994; 368:258-261.
32. Papadopoulos N, Nicolaides N, Wei Y F et al. Mutation of a mutL homolog in Hereditary Colon Cancer. Science 1994; 263: 1625-1628.
33. Nicolaides N C, Papadopoulos N, Liu B et al. Mutations of two PMS homologues in Hereditary NonPolyposis Colon Cancer. Nature 1994; 371: 75-80.
34. Marra G, Chang C L, Laghi L A, Chauhan D P, Young D, Boland C R. Expression of human MutS homolog 2 (hMSH2) protein in resting and proliferating cells. Oncogene 1996; 13:2189-2196.
35. Liu B, Parsons R, Papadopoulos N et al. Analysis of mismatch repair genes in Hereditary Non-Polyposis Colorectal Cancer patients. Nat Med 1996; 2: 169-174.
36. da Costa L T, Wafik E D, Hamilton S R et al. Polymerase ô variants in RER colorectal tumours. Nat Genet 1995; 9: 10-11.
37. Konishi M, Kikuchi-Yanoshita R, Tanaka K et al. Molecular nature of colon tumours in Hereditary Nonpolyposis Colon Cancer, Familial Polyposis, and Sporadic Colon Cancer. Gastroenterology 1996; 111:307-317.
38. Rampino N, Yamamoto H, lonov Y et al. Somatic frameshift mutations in the BAX gene in colon cancer of the mutator phenotype. Science 1997; 275: 967-969.
39. Sankila R, Aaltonen L A, Jarvinen H J, Mecklin J-P. Better survival rates in patients with MLH1-Associated Hereditary Colorectal Cancer. Gastroenterology 1996; 110: 682-687.
40. Lynch HT, Smyrik T. Colorectal cancer, survival advantage, and Hereditary Non-Polyposis Colorectal Carcinoma. Gastroenterology 1996; 110:943-954.
41. Hemminki A, Tomlinson I, Markie D et al. Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat Genet 1997; 15:87-90.
42. Wu T, Rezai B, Rashid A et al. Genetic alterations and epithelial dysplasia in juvenile polyposis syndrome and sporadic juvenile polyps. Am J Pathol 1997; 150: 939-946.
43. Fearon E R, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767.
44. Powell S M, Zilz N, Beazer-Barclay Y et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992; 359: 235-237.
45. Smith A J, Stern H S, Penner M et al. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res 1994; 54:5527-5530.
46. Yamashita N, Minamoto T, Ochiai A, Onda M, Esumi H. Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon. Gastroenterology 1995; 108:434-440.
47. Jen J, Powell S M, Papadopoulos N et al. Molecular determinants of dysplasia in colorectal lesions. Cancer Res 1994; 54: 5523-5526.
48. Buriner G C, Loeb L A. Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma. Proc Natl Acad Sei USA 1989: 86: 2403-2407.
49. Watson A J M, Merritt A J, Jones L S et al. Evidence for reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas. Br J Cancer 1996; 73: 889-895.
50. Chadeneau C, Kazy H, Hirte H W, Gallinger S, Bacchetti S. Telomerase activity associated with the acquisition of malignancy in human colorectal cancer. Cancer Res 1995; 55: 2533-2536.
51. Eberhart C E, Coffey R J, Radhika A et al. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107: 1183-1188.
52. Fearon E R, Cho K R, Nigro J M et al. Identification of a chromosome 18q gene that is altered in colorectal cancer. Science 1990; 247: 49-56.
53. Roush W. Putative cancer gene shows up in development instead. Science 1997; 276:534-535.
54. Fazeli A, Dickinson S L, Hermiston M L et al. Phenotype of mice lacking functional deleted in colorectal cancer (Dec) gene. Nature 1997; 386: 796-804.
55. Vogelstein B, Fearon FR, Hamilton S R et al. Genetic alterations during colorectal cancer. N Engl J Med 1988; 319: 525-532.
56. Tanaka K, Oshimura M, Kikachi R et al. Suppression of tumorigenicity in human colon carcinoma cell lines by introduction of normal chromosome 5 or 18. Nature 1991; 349: 340-342.
57. Baker S J, Preisinger A C, Jessup J M et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 1990; 50: 7717-7722.
58. Dittmer D, Pâti S, Zambetti G et al. Gain of function mutations in p53. Nat Genet 1993; 4:42-46.
59. Lane D P. p53, guardian of the genome. Nature 1992; 358: 15-16.
60. Leister I, Weith A, Bruderlein S et al. Human colorectal cancer: high frequency of deletions at chromosome Ip35. Cancer Res 1990; 50: 7232-7235.
61. Laurent-Puig P, Olschwang S, Delattre O et al. Survival and acquired genetic alterations in colorectal cancer. Gastroenterology 1992; 102: 1136-1141.
62. Yaremko M L, Wasylyshyn M L, Paulus K L, Michelassi F, Westbrook C A. Deletion mapping reveals two regions of chromosome 8 allele loss in colorectal carcinoma. Genes Chromosomes Cancer 1994; 10: 1-6.
63. Fujiwara Y, Ohata H, Emi M et al. A 3-Mb physical map of the chromosome region 8p21. 3-p22, including a 600-kb region commonly deleted in human hepatocellular carcinoma, colorectal cancer and non-small cell lung cancer. Genes Chromosomes Cancer 1994; 10: 7-14.
64. Keldysh P L, Dragani T A, Fleischman E W et al. 1 lq deletions in human colorectal carcinomas: cytogenetics and restriction fraament length polymorphism analysis. Genes Chromosomes Cancer 1993; 6:45-50.
65. Young J, Leggett B, Ward M et al. Frequent loss of heterozygosity on chromosome 14 occurs in advanced colorectal carcinomas. Oncogene 1993; 8: 671-675.
66. Cawkwell L, Lewis F A , Quirke P. Frequency of allele loss of DCC, p53, RB1, WT1, NF1, NM23 and APCA1CC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. Br J Cancer 1994; 70: 813-818.
67. Friend S H, Bernards R, Rogeli S et al. A human DNA segment with properties of the gene that predisposes to human retinoblastoma and osteosarcoma. Nature 1986; 323: 643-646.
68. Wildrick D M, Boman B M. Does the human retinoblastoma gene have a role in colon cancer? Mol Carcinog 1994; 10: 1-7.
69. Aaltonen L A, Peltomaki P, Leach F S et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993; 260:812-816.
70. Thibodeau S N, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993; 260: 816-819.
71. Cawkwell L, Li D, Lewis F A et al. Microsatellite instability in colorectal cancer: improved assessment using fluorescent polymerase chaim reaction. Gastrocnterology 1995; 109:465-471.
72. Kirn H, Jen J, Vogelstein B, Hamilton S R. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 1994; 145: 148-156.
73. Bubb V J, Curtis L C, Cunningham C et al. Microsatellite instability and the role of HMSH2 in sporadic colorectal cancer. Oncogene 1996; 12: 2641-2649.
74. Liu B, Nicolaides N, Markowitz S et al. Mismatch repair gene defects in sporadic colorectal cancer with microsatellite instability. Nat Genet 1995; 9:48-55.
75. Samowitz W S, Slattery M L. Microsatellite instability in colorectal adenomas. Gastroenterology 1997; 112: 1515-1519.
76. Watanable T, Muto R, Sawada T et al. Flat adenoma as a precursor of colorectal carcinoma in Hereditary Non-Polyposis Colorectal Carcinoma. Cancer 1996; 77: 627-634.
77. Greenwald B D, Harpaz N, Yin J et al. Loss of heterozygosity affecting the p53, Rb, and MCC/APC tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis. Cancer Res 1992; 52: 741-745.
78. Kern S E, Redstone M, Seymour A B et al. Molecular genetic profiles of colitis-associated neoplasms. Gastroenterology 1994; 107: 420-428.
79. Suzuki H, Harpaz N, Tannin Y et al. Microsatellite instability in ulcerative-colitis associated dysplasias and cancers. Cancer Res 1994; 54:4841-4844.
80. Yin J, Harpaz N, Tong Y et al. p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology 1993; 104: 1633-1639.
81. Banerjee A K. DCC expression and prognosis in colorectal cancer. Lancet 1997; 349: 968.
82. Shibata D, Reale M A, Lavin P et al. The DCC protein and prosnosis in colorectal cancer. N Engl J Med 1996; 335: 1727-1732.
83. Kastan M B, Canman C E, Leonard C J. P53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev 1995; 14:3-15.
84. Li Z H, Salovaara R, Aaltonen L A, Shibata D. Telomerase activity is commonly detected in Hereditary Nonpolyposis Colorectal Cancers. Am J Pathol 1996; 148: 1075-1078.
85. Yoshida K, Sugino T, Goodison S et al. Detection of telomerase activity in exfoliated cancer cells in colonie luminal washings and its related clinical implications. Br J Cancer 1997; 75: 548-553.
86. Sidransky D, Tokino T, Hamilton S R et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumour. Science 1992; 256: 102-105.
87. Villa E, Dugani A, Rebecchi A M et al. Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool. Gastroenterology 1996; 110: 1346-1353.
88. Eguchi S, Kohara N, Komuta K, Kanematsu T. Mutations of the p53 gene in the stool of patients with resectable colorectal cancer. Cancer suppl. 1996; 778: 1707-1710.